Nepafenac
FDA Approved: * October 16, 2012Pharm Company: * ALCON RES
Category: Vision / Eye Health
Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery.[2] Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 activity.[3][4] Contents 1 Medical uses 2 Pharmacology 2.1 Mechanism of action 3 Adverse events 4 ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.